Last update:
Medications news
Medications
New malaria drug heralds resistance breakthrough
The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.
2 hours ago
0
0
Medications
Medications change our gut microbiome in predictable ways, research reveals
Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve ...
11 hours ago
0
36
Tirzepatide may only temporarily suppress brain 'food noise' activity
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain's "reward center" ...
14 hours ago
0
9
Researchers study omega-3 fatty acids as a way to prevent preterm birth
SAHMRI's long-term research into omega-3 fatty acids as a way to prevent preterm birth is set to improve antenatal care across the globe.
5 hours ago
0
0
How a new drug kills sleeping sickness parasites by damaging their DNA
Trypanosomatids are parasites that can result in more than 1 billion potentially fatal infections per year globally. In Africa, Human African Trypanosomiasis (HAT), better known as sleeping sickness, causes a devastating ...
11 hours ago
0
0
One of the world's oldest blood pressure drugs may also halt aggressive brain tumor growth
A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for preeclampsia, works at the molecular level. In doing so, they made a surprising discovery—it can ...
Nov 16, 2025
0
186
US narrows use of muscle-wasting therapy after teen deaths
The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating muscle-wasting disease, and also limit its approved use.
Nov 15, 2025
0
0
When life imitates art: Google searches for anxiety drug spike during run of The White Lotus TV show
In season three of the hit television series "The White Lotus," the character Victoria Ratliff takes the prescription anti-anxiety medication lorazepam to help with her social anxiety and inability to sleep. Her casual usage ...
Nov 14, 2025
0
5
GLP-1 and health: Beyond weight loss in the Ozempic era
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people ...
Nov 14, 2025
0
0
Family history key to predicting antidepressant response
A new study from Queen Mary University of London shows that a family's experience with certain medicines could help doctors predict how future generations will respond to the same drugs.
Nov 13, 2025
0
0
New pill cuts 'bad' cholesterol by 60%, potentially replacing injections
A new pill from Merck could change how millions of people treat high cholesterol and help prevent heart attacks and strokes without the need for injections.
Nov 13, 2025
0
26
Two drugs that treat prostate cancer may also be effective against leukemia
Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn State. AML, a cancer of blood ...
Nov 13, 2025
0
0
What's a 'black box' warning? A pharmacologist explains how these labels protect patients
A "black box" warning on a health product sounds pretty scary—maybe even more so when it's suddenly being taken off the packaging.
Nov 13, 2025
0
0
FDA approves Darzalex Faspro for high-risk smoldering multiple myeloma
The U.S. Food and Drug Administration has approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) as a single-agent treatment for adult patients with high-risk smoldering multiple myeloma (HR-SMM).
Nov 13, 2025
0
23
FDA approves Caplyta for major depressive disorder in adults
The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults.
Nov 13, 2025
0
1
Metformin as a new standard of care to manage weight gain side effect of certain bipolar medications
Results from the largest and longest study of its kind have found that the drug metformin can help manage weight gain in overweight or obese youth taking medication to treat bipolar disorder, and should be adopted as a standard ...
Nov 12, 2025
0
36
Common gout drug may reduce risk of heart attack and stroke
A widely used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new review.
Nov 12, 2025
0
27
Extending anti-clotting treatment linked to lower rates of new clots
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published ...
Nov 12, 2025
0
0
As GLP-1 drugs go mainstream, this expert says health is more than a number on a scale
Popular weight-loss drugs known as GLP-1s could soon become more affordable for Americans. On Thursday, the Trump administration and two major drugmakers announced an agreement to drastically reduce the cost of the drugs ...
Nov 12, 2025
0
0
Once-weekly eloralintide leads to 20% weight loss in Phase II trial
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.
Global use of antiseizure drug linked to birth defects is on the rise
In a study carried out in collaboration with the World Health Organization, two Aston University academics have found that while access to antiseizure medication in low- and middle-income countries is growing, it is not necessarily ...
Nov 11, 2025
0
58
Experimental compound curbs alcohol intake and motivation in mice, with sex-dependent differences
A new compound tested at the Miguel Hernández University of Elche (UMH) in Spain shows promising effects in reducing alcohol consumption and motivation to drink in mice, with marked sex-dependent differences in efficacy. ...
Nov 11, 2025
0
0
Poisonings from ADHD medication have quadrupled in the last ten years
More than 3,000 Australians were poisoned by medications for attention deficit hyperactivity disorder in 2023, a fourfold increase on the 795 cases recorded in 2014 to 3242 in 2023, new research from the University of Sydney ...
Nov 11, 2025
0
0
LDL cholesterol improved among veterans in program with health coaches, other resources
A quality improvement program helped reduce "bad cholesterol" (LDL or low-density lipoprotein) levels among military veterans who have heart and blood vessel disease, according to a preliminary late-breaking science presentation ...
Nov 11, 2025
0
0
Cannabis dispensaries lead to reduced opioid prescriptions: Studies among first to support plausible causation
Cannabis may be a pain-management substitute for people experiencing chronic or acute pain from conditions like cancer, according to new research from the University of Georgia.
Nov 10, 2025
0
38
